LIGAND PHARMACEUTICALS INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $209.29 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-02-27
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $209.29M.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $71.54M.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $8.78M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $30.48M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2025-12-31 | $209.29M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $71.54M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $8.78M 10-K · filed 2026-02-27 | |
| 2022-12-31 | $30.48M 10-K · filed 2026-02-27 | |
| 2022-10-31 | $14.84M 10-K · filed 2025-02-28 | |
| 2021-12-31 | $113.30M 10-K · filed 2025-02-28 | |
| 2020-12-31 | $59.03M 10-K · filed 2024-02-29 | |
| 2019-12-31 | $72.00M 10-K · filed 2023-02-28 | |
| 2018-12-31 | $125.86M 10-K · filed 2022-02-28 | |
| 2017-12-31 | $157.34M 10-K · filed 2021-02-24 | |
| 2016-12-31 | $104.25M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $124.80M 10-K · filed 2017-02-28 | $124.88M 10-K · filed 2016-02-26 |
| 2015-06-30 | $120.59M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $89.58M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $51.56M 10-K · filed 2016-11-14 | $62.70M 10-K · filed 2014-12-01 |
| 2014-09-30 | $43.20M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $66.39M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $75.53M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $62.70M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $48.32M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $40.56M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $21.64M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $11.36M 10-K/A · filed 2014-12-12 | |
| 2011-12-31 | $1.49M 10-K/A · filed 2014-12-12 | |
| 2010-12-31 | $9.00K 10-K/A · filed 2014-12-12 | |
| 2009-12-31 | $31.00K 10-K · filed 2013-03-14 |